R&G PharmaStudies Co., Ltd.: what insiders have been doing
R&G PharmaStudies Co., Ltd. has a thin disclosure history in our data (latest filing: 28 November 2022). New filings will appear here as soon as they are published. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 800 shares100.0% of flowA股XSHESZSE:173000006083972220
1 of 1 declaration
About R&G PharmaStudies Co., Ltd.
诺思格 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHE market. It focuses on the development and commercialization of innovative pharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
